One month after portal hypertension we assayed in the splanchnic area (liver, small bowel and mesenteric lymph nodes) and in the central nervous system (hippocampus and cerebellum) fractalkine (CX3CL1) and stromal cell-derived factor alpha (SDF1-Î±) as well as their respective receptors (CX3CR1 and CXCR4) because of their key role in inflammatory processes
